Wed, March 8, 2023
Tue, March 7, 2023
Mon, March 6, 2023
Fri, March 3, 2023
Thu, March 2, 2023

Eric Joseph Upgraded (VIR) to Buy and Decreased Target to $34 on, Mar 6th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -and-decreased-target-to-34-on-mar-6th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Eric Joseph of JP Morgan, Upgraded "Vir Biotechnology, Inc." (VIR) to Buy and Decreased Target from $35 to $34 on, Mar 6th, 2023.

Eric has made no other calls on VIR in the last 4 months.



There are 4 other peers that have a rating on VIR. Out of the 4 peers that are also analyzing VIR, 1 agrees with Eric's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Michael Ulz of "Morgan Stanley" Upgraded from Sell to Hold and Increased Target to $30 on, Friday, January 27th, 2023


These are the ratings of the 3 analyists that currently disagree with Eric


  • Joseph Stringer of "Needham" Reiterated at Strong Buy and Held Target at $32 on, Friday, February 24th, 2023
  • Paul Choi of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $53 on, Thursday, February 23rd, 2023
  • Roanna Ruiz of "SVB Leerink" Maintained at Buy with Decreased Target to $43 on, Friday, January 27th, 2023

Publication Contributing Sources